OVID
Ovid Therapeutics Inc.Company with tickers: OVID
CIK
1636651
CUSIP
690469101
Shares Outstanding
186,640,102
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $0 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $17,846,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $11,181,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-17,846,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-16,988,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |